ClinConnect ClinConnect Logo
Search / Trial NCT06001983

Effect of Imaginary Resisted Therapy Versus Physical Resisted Therapy on Hemiplegic Cerebral Palsy

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Aug 18, 2023

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Hemiplegic Cerebral Palsy, Hand Grip Strength, Imaginary Resisted Exercises, Physical Resisted Exercises.

ClinConnect Summary

This clinical trial is studying two different types of exercises to see which one helps improve hand grip strength in children with hemiplegic cerebral palsy, a condition that affects one side of the body. The researchers want to compare "imaginary resisted exercises," where children imagine doing a workout, against "physical resisted exercises," which involve actual physical movement. The goal is to find out which method is more effective for improving strength in the affected hand.

The study is looking for children aged 6 to 12 years who have congenital hemiplegia (a type of cerebral palsy present at birth) and do not use their affected arm much. To join, kids should have a certain level of ability to use their hands and have a specific level of muscle tightness. However, children with certain conditions, like severe muscle stiffness, recent surgeries, or uncontrolled epilepsy, will not be eligible to participate. If eligible, children will engage in either type of exercise over the course of the trial, and the researchers will monitor their progress in hand strength. This study is currently recruiting participants, and it's a great opportunity to potentially help improve treatment options for hemiplegic cerebral palsy.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Congenital infantile hemiplegia.
  • Aged between 6 and 12 years.
  • Lack of use of the affected upper limb.
  • Level I-III of the Manual Ability Classification System (MACS).
  • Students scoring of Modified Ashworth Scale should be 3 or less than 3 out of 5 for the same muscle groups of previously mentioned movements.
  • Exclusion Criteria:
  • Low cognitive level compatible with attending a special education school.
  • Presence of contractures in the affected upper limb affecting the functional movement.
  • Surgery in the six months previously to the treatment.
  • Botulinum toxin in the two months previously to or during the intervention.
  • Pharmacologically uncontrolled epilepsy

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Lahore, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Dr. Nosheen Manzoor, MS OMPT

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported